2m 2m 2m 2m 2m 2m 2m
NewMarket (NEU)
NYSE
$782.76+$2.57 (+0.33%)
Price as of Jun 23, 2026 3:34 PM EDT- $7.2BMarket Cap
- 17.29%1-Year Change
- Specialty ChemicalsIndustry
NewMarket (NEU)
$782.76+$2.57 (+0.33%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.7B -2.20% | 2.8B +3.27% | 2.7B -2.40% | 2.8B +17.35% | |
Cost of Revenue | 1.9B -1.71% | 1.9B -1.33% | 1.9B -9.34% | 2.1B +17.47% | |
Gross Profit | 857.4M -3.27% | 886.3M +14.74% | 772.5M +20.61% | 640.5M +16.94% | |
Sales and Marketing Expense | 181.6M +5.93% | 171.4M +13.17% | 151.5M +4.39% | 145.1M -0.59% | |
Research and Development Expense | -132.1M +5.76% | -124.9M -9.49% | -138.0M -1.61% | -140.3M -2.57% | |
Depreciation and Amortization Expense | 122.4M +4.67% | 117.0M +49.93% | 78.0M -5.20% | 82.3M -2.41% | |
Total Operating Expenses | 1.9B -1.71% | 1.9B -1.33% | 1.9B -9.34% | 2.1B +17.47% | |
Operating Profit | 543.7M -7.85% | 590.0M +22.15% | 483.0M +36.02% | 355.1M +37.77% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -39.7M -30.81% | -57.4M +53.55% | -37.4M +6.13% | -35.2M +2.88% | |
Interest Income and Expense and Net | -39.7M -30.81% | -57.4M +53.55% | -37.4M +6.13% | -35.2M +2.88% | |
Total Nonoperating Income and Expense | 56.5M +9.90% | 51.4M +18.86% | 43.3M +22.45% | 35.3M +47.34% | |
Income before Taxes | 560.6M -4.03% | 584.1M +19.46% | 489.0M +40.61% | 347.7M +40.47% | |
Income Taxes | 141.8M +16.53% | 121.7M +21.57% | 100.1M +46.78% | 68.2M +20.40% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 418.7M -9.44% | 462.4M +18.91% | 388.9M +39.11% | 279.5M +46.43% | |
Net Income from Continuing Operations Applicable to Common | 560.6M -4.03% | 584.1M +19.46% | 489.0M +40.61% | 347.7M +40.47% | |
Basic EPS and Net Income | 44.44 -7.84% | 48.22 +19.24% | 40.44 +45.62% | 27.77 +56.80% | |
Diluted EPS and Net Income | 44.44 -7.84% | 48.22 +19.24% | 40.44 +45.62% | 27.77 +56.80% | |
Basic Weighted Average Shares | 9.4M -1.77% | 9.6M -0.29% | 9.6M -4.50% | 10.0M -6.70% | |
Diluted Weighted Average Shares | 9.4M -1.77% | 9.6M -0.29% | 9.6M -4.50% | 10.0M -6.70% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 77.6M +0.16% | 77.5M -30.79% | 111.9M +62.91% | 68.7M -17.52% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 77.6M +0.16% | 77.5M -30.79% | 111.9M +62.91% | 68.7M -85.04% | |
Total Current Assets | 1.1B +2.93% | 1.0B -0.96% | 1.0B -12.80% | 1.2B -14.12% | |
Accumulated Depreciation | 1.1B +5.61% | 1.0B +2.96% | 991.3M +5.87% | 936.4M +2.62% | |
Property and Plant and Equipment and Net | 775.5M +5.46% | 735.4M +12.31% | 654.7M -0.80% | 660.0M -2.48% | |
Total Long-Term Assets | 51.8M -1.40% | 52.5M +8.97% | 48.2M -24.23% | 63.6M +16.24% | |
Total Assets | 3.5B +11.60% | 3.1B +35.54% | 2.3B -4.07% | 2.4B -5.93% | |
Income Taxes Payable | 17.2M +8.81% | 15.8M +157.67% | 6.1M -61.94% | 16.1M +262.65% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 419.3M +11.96% | 374.5M +2.83% | 364.2M -14.09% | 423.9M -41.54% | |
Total Long-Term Debt | 883.4M -9.05% | 971.3M +50.91% | 643.6M -35.88% | 1.0B +27.08% | |
Total Long-Term Liabilities | 349.5M +30.68% | 267.4M +58.28% | 169.0M -0.50% | 169.8M -25.77% | |
Total Liabilities | 1.7B +2.77% | 1.7B +35.41% | 1.2B -25.09% | 1.6B -8.46% | |
Retained Earnings | 1.7B +16.82% | 1.4B +30.36% | 1.1B +31.35% | 834.4M -1.18% | |
Total Stockholders Equity | 1.8B +21.67% | 1.5B +35.70% | 1.1B +41.27% | 762.4M +0.04% | |
Total Shares Outstanding | 9.4M -1.34% | 9.5M -0.68% | 9.6M -1.16% | 9.7M -6.37% | |
Cash Flow | |||||
Cash from Operating Activities | 569.0M +9.50% | 519.6M -9.92% | 576.8M +431.05% | 108.6M -34.30% | |
Capital Expenditures | 77.6M +35.45% | 57.3M +18.69% | 48.3M -14.02% | 56.2M -28.84% | |
Cash from Investing Activities | -291.1M -60.60% | -738.8M +1,429.82% | -48.3M -115.29% | 315.9M +168.46% | |
Dividends Paid | 105.9M +10.46% | 95.9M +12.78% | 85.0M +0.91% | 84.3M -1.92% | |
Cash from Financing Activities | -279.1M -250.23% | 185.8M +138.11% | -487.6M +10.98% | -439.4M -272.21% | |
Financials Ratio | |||||
Gross Margin | 31.46% -1.09% | 31.81% +11.11% | 28.63% +23.58% | 23.17% -0.34% | |
Operating Margin | 19.95% -5.77% | 21.17% +18.29% | 17.90% +39.36% | 12.85% +17.40% | |
Return on Assets | 12.65% -25.63% | 17.01% +3.11% | 16.49% +46.47% | 11.26% +32.48% | |
Return on Equity | 25.85% -29.04% | 36.43% -13.84% | 42.28% +15.29% | 36.67% +46.18% | |
Revenue Growth | -2.20% -167.45% | 3.27% +236.04% | -2.40% -113.84% | 17.35% +1.05% | |
Current Ratio | 2.53 -8.07% | 2.75 -3.69% | 2.85 +1.50% | 2.81 +46.90% | |
Cash Ratio | 0.19 -10.54% | 0.21 -32.69% | 0.31 +89.64% | 0.16 +41.08% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 1.32 -11.93% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.42 -6.36% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow